cognitive-impairment

Documents about cognitive-impairment

• Devinime ilişkin kortikal potansiyellerin hafif bilişsel bozukluk ve orta evre alzheimer hastalığını değerlendirmede nöropsikoljik testler ile korelasyonu#458514Necmettin Erbakan University Institutional Repository
• Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping#850012ClinicalTrials.gov
• A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions#861087ClinicalTrials.gov
• Rehabilitation Through Hippotherapy for the Management of Women After Primary Treatment of Breast Cancer#878383ClinicalTrials.gov
• Depression-, Anxiety-, and Anger and Cognitive Functions: Findings From a Longitudinal Prospective Study#491917eScholarship
• Noninvasive Brain Stimulation Techniques and Their Efficacy in Treating Cognition and Memory in Mild Cognitive Impairment and Alzheimer’s Disease—A Systematic Review#231264Europe PMC
• Niveles de sobrecarga, actividad física, ansiedad, depresión y calidad de vida en cuidadores principales informales de personas con deterioro cognitivo: un estudio transversal#273720Gestión del Repositorio Documental de la Universidad de Salamanca
• A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease#805144ClinicalTrials.gov
• NeuroCare Community Project: A Community Based Prospective Observational Study for Early Alzheimer's Detection in HK#881426ClinicalTrials.gov
• Programa de entrenamiento de equilibrio vs Programa de entrenamiento de equilibrio con tareas de atención en deterioro cognitivo derivado de accidente cerebrovascular#273713Gestión del Repositorio Documental de la Universidad de Salamanca
• Table 1_Ershiwuwei Shanhu Pill ameliorates cognitive impairment in Alzheimer’s disease mice by remodeling gut microbiota and host serum metabolites.xls#291333Figshare
• A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication#810236ClinicalTrials.gov
• ADAI - Home Care in Intelligent Environments Clinical Care Ecosystem for the Management of Home Digital Therapies Through the Use of Assistive Robots and Clinical Predictive Systems Based on Artificial Intelligence Systems#162355ClinicalTrials.gov
• Programa de entrenamiento de equilibrio a través de ejercicios con dobles tareas en pacientes con deterioro cognitivo secundario a un accidente cerebrovascular: un estudio de intervención#273710Gestión del Repositorio Documental de la Universidad de Salamanca
• Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech#805905ClinicalTrials.gov
• Milk Fat Globule Membrane-Enhanced RUTF for Children With Severe Acute Malnutrition#836177ClinicalTrials.gov
• A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease#840108ClinicalTrials.gov
• Cognition and MRI Markers in MS Patients With Aubagio® Treatment#872049ClinicalTrials.gov
• The constrained brain in multiple sclerosis: Cognitive impairment is related to network-specific coupling of structural and functional connectivity#317442HAL (France)
• White matter tract injury and cognitive impairment in human immunodeficiency virusinfected individuals#675895eScholarship
• Resting-State EEG Alpha Rhythms Are Related to CSF Tau Biomarkers in Prodromal Alzheimer's Disease#185646IRIS
• A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's Disease#852857ClinicalTrials.gov
• Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer’s disease with hydromethylthionine mesylate using external control data✰✰✰#123242Europe PMC
• Assessment of clinical and neuroimaging efficacy of treatment targeting tau pathology in mild cognitive impairment and mild to moderate Alzheimer's disease with hydromethylthionine mesylate using external control data#125809Europe PMC
• Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers#675929eScholarship
• A universal neocortical mask for Centiloid quantification#492045eScholarship
• The effects of cognitive impairment on nursing home residents' emergency department visits and hospitalizations#683960eScholarship
• Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer's disease#182053Europe PMC
• Crossed cerebellar diaschisis on 18F-FDG PET: Frequency across neurodegenerative syndromes and association with 11C-PIB and 18F-Flortaucipir#491885eScholarship
• Model organism development and evaluation for late‐onset Alzheimer's disease: MODEL‐AD#619913eScholarship
• Development and assessment of a composite score for memory in the Alzheimer’s Disease Neuroimaging Initiative (ADNI)#634849eScholarship
• The Impact of 6-months of Resistance Training on Brain and Muscle Health in Older Adults With MCI#830891ClinicalTrials.gov
• Abnormal vocal behavior predicts executive and memory deficits in Alzheimer's disease#634708eScholarship
• The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All#784275eScholarship
• Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers#612146eScholarship
• An active lifestyle is associated with better neurocognitive functioning in adults living with HIV infection#675821eScholarship
• A history of alcohol dependence augments HIV-associated neurocognitive deficits in persons aged 60 and older#675823eScholarship
• Down syndrome: Distribution of brain amyloid in mild cognitive impairment#491982eScholarship
• Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection#612174eScholarship
• Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic#867252ClinicalTrials.gov
• Spatial coupling of enlarged perivascular spaces and white matter lesions across the Alzheimer's disease continuum#620130eScholarship
• Genetically elevated high‐density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease#634797eScholarship
• Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer’s disease#675974eScholarship
• Randomized Controlled Trial Testing the Efficacy of Transcranial Magnetic Stimulation by Accelerated & High-dose Theta-burst, Functional Imaging Guided, in the Treatment of Depression in Elderly Subjects With Cognitive Impairment#866364ClinicalTrials.gov
• Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty#614653eScholarship
• Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models#612040eScholarship
• Peripheral Elevation of a Klotho Fragment Enhances Brain Function and Resilience in Young, Aging, and α-Synuclein Transgenic Mice#675927eScholarship
• Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice#634738eScholarship
• Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features#614704eScholarship
• RCT of HeartBot in Women#846901ClinicalTrials.gov